08:00 , Jan 2, 2001 |  BioCentury  |  Finance

Ebb & Flow

Prudential's plans to overhaul its securities unit, which include a major reduction in its investment banking presence, has left the future of Prudential Vector Securities up in the air. Pru acquired Vector in 1999 to...
08:00 , Dec 18, 2000 |  BC Extra  |  Financial News

Circe raises $28 million

Circe (Lexington, Mass.), which is in Phase II/III testing with its HepatAssist Liver Support System, raised $28 million in a private round. Investors included Asahi Chemical; Burrill; HLM Management; Advanced Technology Ventures; SenMed Medical Ventures;...
08:00 , Mar 20, 2000 |  BC Week In Review  |  Company News

Array BioPharma, Asahi Chemical Industry Co. Ltd. deal

Array will provide Asahi with semi-exclusive access to its small molecule libraries. Array's libraries are directed at targets that include G protein-coupled and nuclear receptors, enzymes and protein-protein interactions. Array BioPharma Inc., Boulder, Colo.  ...
08:00 , Mar 13, 2000 |  BC Extra  |  Company News

Small molecule libraries deal

Array BioPharma (Boulder, Colo.) will provide Asahi Chemical Industry (Tokyo, Japan) with semi-exclusive access to its small molecule libraries. Array BioPharma's libraries are directed at targets that include G protein-coupled receptors, nuclear receptors, enzymes and...
07:00 , Apr 12, 1999 |  BC Week In Review  |  Company News

Molecumetics Ltd., Asahi Chemical Industry Co. Ltd. deal

The companies will use Molecumetics’ SMART Library to select targets to treat central nervous system, cardiovascular, inflammatory and metabolic conditions. Molecumetics will identify leads, and Asahi is responsible for preclinical development. Molecumetics will receive research...
07:00 , Sep 22, 1997 |  BC Week In Review  |  Company News

Biostar, Asahi Chemical Co. Ltd. deal

The companies will develop a multi-analysis, point-of-care system to detect infectious diseases using BioStar's thin film and ellipsometer technologies. Asahi will pay an initial license fee, option fees and fund instrument system and reagent development....
07:00 , Aug 25, 1997 |  BioCentury  |  Emerging Company Profile

Molecumetics Ltd,

Molecumetics Ltd. Bellevue, Wash. Technology: SMART Library technology for the design and synthesis of drug candidates Disease focus: Cardiovascular disease, inflammation, and cancer Clinical status: Preclinical Founded: 1992 by Michael Kahn and Tredegar Industries Corporate...
07:00 , Aug 25, 1997 |  BioCentury  |  Emerging Company Profile

Molecumetics: Superfamily scaffolds

Emerging Company Profile Working from the general to the specific is one way to learn how to discover new drugs. That's the strategy being pursued by Molecumetics Ltd., which conducts drug discovery by starting with...
07:00 , May 27, 1997 |  BC Week In Review  |  Company News

Molecumetics Ltd., Asahi Chemical Industry Co. Ltd. deal

The companies will use Molecumetics' SMART Library technology to discover and develop orally active inhibitors of Factor VIIa , a protease in the blood coagulation cascade. Molecumetics will identify and optimize compounds that Asahi will...
08:00 , Dec 18, 1995 |  BC Week In Review  |  Company News

Inhale Therapeutic Systems, Asahi Chemical Industry Co. Ltd. deal

INHL and Asahi agreed to test a pulmonary version of one of the Japanese company's drugs for osteoporosis. Under the agreement, INHL will develop a dry-powder formulation of the drug for use with its pulmonary...